Literature DB >> 20575089

Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.

Don Hayes1, Susan E West, Michael J Rock, Zhanhai Li, Mark L Splaingard, Philip M Farrell.   

Abstract

BACKGROUND: Chronic pulmonary infection with Pseudomonas aeruginosa (PA) is responsible for significant morbidity and mortality in cystic fibrosis (CF). Because of the limited studies evaluating early exposure and the progression of genetic variability of PA, our goal was to assess PA in young children with CF followed in two clinic types.
METHODS: A total of 39 infants with CF diagnosed through newborn screening were randomly assigned to either a segregated (PA-free) or mixed (PA-positive) clinic at two different CF centers, one of which replaced an older, mixed clinic where nosocomial acquisition was suspected. Oropharyngeal (OP) swab cultures were examined with subsequent genotyping to characterize the strains of PA isolated.
RESULTS: We found that 13/21 segregated clinic patients and 14/18 mixed clinic patients showed positive PA, with median acquisition ages of 3.3 and 2.2 years, respectively (P = 0.57). The median time to PA acquisition, however, was significantly longer in the new clinic with proper hygiene precautions compared to an old site (5.0 years vs. 1.7 years, P < 0.001). The majority of subjects isolated a single genotype of PA or AP-PCR types during the study period with eight subjects clearing the isolate after only one positive culture. The development of chronic colonization yielded the predominance of a single major genotype or AP-PCR type.
CONCLUSIONS: Segregation of infants and young children with CF in PA-negative or PA-positive clinics did not alter the time to first PA isolation in this randomized assessment of facilities with hygienic precautions. During the early infection period where PA is first isolated in young children with CF, patients cleared different PA strains until a predominant strain established permanent colonization.

Entities:  

Mesh:

Year:  2010        PMID: 20575089      PMCID: PMC2921980          DOI: 10.1002/ppul.21263

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  34 in total

1.  To cohort or not to cohort: how transmissible is Pseudomonas aeruginosa?

Authors:  Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2002-10-01       Impact factor: 21.405

2.  Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: A registry-based longitudinal study.

Authors:  S S Wang; S C FitzSimmons; L A O'Leary; M J Rock; M L Gwinn; M J Khoury
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

3.  Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa.

Authors:  S J McCallum; J Corkill; M Gallagher; M J Ledson; C A Hart; M J Walshaw
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

4.  Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

Authors:  A M Jones; J R Govan; C J Doherty; M E Dodd; B J Isalska; T N Stanbridge; A K Webb
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

5.  Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Authors:  P M Farrell
Journal:  Adv Pediatr       Date:  2000

6.  Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.

Authors:  M R Kosorok; L Zeng; S E West; M J Rock; M L Splaingard; A Laxova; C G Green; J Collins; P M Farrell
Journal:  Pediatr Pulmonol       Date:  2001-10

7.  Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization.

Authors:  A Munck; S Bonacorsi; P Mariani-Kurkdjian; M Lebourgeois; M Gérardin; N Brahimi; J Navarro; E Bingen
Journal:  Pediatr Pulmonol       Date:  2001-10

8.  Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa.

Authors:  Karen O McKay; Peter J Cooper; Peter P van Asperen
Journal:  J Cyst Fibros       Date:  2009-08-27       Impact factor: 5.482

9.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

Authors:  Julia Emerson; Margaret Rosenfeld; Sharon McNamara; Bonnie Ramsey; Ronald L Gibson
Journal:  Pediatr Pulmonol       Date:  2002-08

10.  Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.

Authors:  Susan E H West; Lan Zeng; Bee Leng Lee; Michael R Kosorok; Anita Laxova; Michael J Rock; Mark J Splaingard; Philip M Farrell
Journal:  JAMA       Date:  2002-06-12       Impact factor: 157.335

View more
  5 in total

1.  Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.

Authors:  Margaret Rosenfeld; Julia Emerson; Sharon McNamara; Valeria Thompson; Bonnie W Ramsey; Wayne Morgan; Ronald L Gibson
Journal:  J Cyst Fibros       Date:  2012-05-01       Impact factor: 5.482

Review 2.  Epidemiology and Ecology of Opportunistic Premise Plumbing Pathogens: Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa.

Authors:  Joseph O Falkinham; Elizabeth D Hilborn; Matthew J Arduino; Amy Pruden; Marc A Edwards
Journal:  Environ Health Perspect       Date:  2015-03-20       Impact factor: 9.031

3.  Phenotypic characterization and PCR-Ribotypic profile of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran.

Authors:  Hossein Fazeli; Reza Akbari; Sharare Moghim; Bahram Nasr Esfahani
Journal:  Adv Biomed Res       Date:  2013-03-06

4.  Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.

Authors:  Danieli B Salinas; Patrick R Sosnay; Colleen Azen; Suzanne Young; Karen S Raraigh; Thomas G Keens; Martin Kharrazi
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

5.  Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis.

Authors:  Taylor E Woo; Rachel Lim; Michael G Surette; Barbara Waddell; Joel C Bowron; Ranjani Somayaji; Jessica Duong; Christopher H Mody; Harvey R Rabin; Douglas G Storey; Michael D Parkins
Journal:  ERJ Open Res       Date:  2018-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.